AcquisitionElevation Oncology, Inc. announced an acquisition agreement with Concentra Biosciences, which includes a cash per share offer plus a Contingent Value Right.
Shareholder SupportELEV officers, directors, and their respective affiliates, representing about 5.1% of common stock, have signed agreements to tender their shares in support of the merger.